Gobindram Avinash, Yek Jia Lin Jacklyn, Tan Alvin Kah Leong, Chan Yiong Huak, Lee Joyce Lai Ying, Hsu Pon Poh
Department of Anaesthesia and Surgical Intensive Care, Changi General Hospital, 2 Simei Street 3, Singapore.
Department of Otorhinolaryngology, Changi General Hospital, 2 Simei Street 3, Singapore.
Indian J Anaesth. 2021 Sep;65(9):676-683. doi: 10.4103/ija.ija_592_21. Epub 2021 Oct 8.
One in six Singaporeans has obstructive sleep apnoea (OSA) due to obesity compounded by inherent craniofacial features. We assessed the incidence of cardiopulmonary complications and the effectiveness of continuous positive airway pressure (CPAP) therapy in minimising such complications within an obese population.
A retrospective study of elective noncardiac surgical patients with a body mass index ≥32 kg/m was conducted. Patients at moderate to severe risk of OSA were offered CPAP therapy. CPAP therapy adherence, postoperative complications, length of hospital stay, and type of anaesthesia were analysed.
In total, 1400 patients comprising 174 with low risk of OSA (L-OSA) and 1226 with moderate to high risk of OSA were included. Of these, 332 were started on CPAP therapy (C-OSA) while 894 declined CPAP use (R-OSA). There were 10 (0.05%) cardiac events - one (0.6%) in the L-OSA group, six (0.6%) in the R-OSA group and three (0.9%) in the C-OSA group. There were 37 (2.6%) respiratory events - 2 (1.1%) in the L-OSA group, 23 (2.6%) in the R-OSA group, and 12 (3.6%) in the C-OSA group. Multivariate analysis showed no statistical significance in CPAP therapy minimising cardiac ( = 0.147) and respiratory ( = 0.255) complications, when analysed by intention-to-treat. CPAP therapy adherence was 13.6 and 10.2% pre- and postoperatively, respectively. When analysed per protocol, none of the nine patients compliant with both pre- and postoperative CPAP therapy developed cardiopulmonary complications.
Amongst patients with moderate to severe risk of OSA, those who were compliant to perioperative CPAP therapy demonstrated a reduction in cardiopulmonary complications.
六分之一的新加坡人因肥胖以及先天性颅面特征而患有阻塞性睡眠呼吸暂停(OSA)。我们评估了肥胖人群中心肺并发症的发生率以及持续气道正压通气(CPAP)治疗在将此类并发症降至最低方面的有效性。
对体重指数≥32 kg/m²的择期非心脏手术患者进行回顾性研究。向中度至重度OSA风险患者提供CPAP治疗。分析了CPAP治疗依从性、术后并发症、住院时间和麻醉类型。
总共纳入了1400例患者,其中174例为低OSA风险(L-OSA),1226例为中度至高OSA风险。其中,332例开始接受CPAP治疗(C-OSA),而894例拒绝使用CPAP(R-OSA)。发生了10例(0.05%)心脏事件——L-OSA组1例(0.6%),R-OSA组6例(0.6%),C-OSA组3例(0.9%)。发生了37例(2.6%)呼吸事件——L-OSA组2例(1.1%),R-OSA组23例(2.6%),C-OSA组12例(3.6%)。多因素分析显示,按意向性分析,CPAP治疗在降低心脏(P = 0.147)和呼吸(P = 0.255)并发症方面无统计学意义。CPAP治疗依从性术前和术后分别为13.6%和10.2%。按方案分析时,术前和术后均依从CPAP治疗的9例患者中无一例发生心肺并发症。
在中度至重度OSA风险患者中,围手术期依从CPAP治疗的患者心肺并发症有所减少。